Evidence map›Paper›PMID 40663189›Full record

SynthesisInternational journal of implant dentistry2025

New bone formation of biphasic calcium phosphate bone substitute material: a systematic review and network meta-analysis of randomized controlled trials (RCTs).

Chutikarn Somngam, Sutiwat Samartkit, Sukrit Kanchanasurakit, Frank Peter Strietzel, Pathawee Khongkhunthian

Abstract readNetwork Meta-AnalysisSystematic Review
In one paragraph

Synthesis in International journal of implant dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chutikarn SomngamCenter of Excellence for Dental Implantology, Faculty of Dentistry, Chiang Mai University, Chiang Mai, 50200, Thailand.
Sutiwat SamartkitCenter of Excellence for Dental Implantology, Faculty of Dentistry, Chiang Mai University, Chiang Mai, 50200, Thailand.
Sukrit KanchanasurakitCenter of Health Outcomes Research and Therapeutic Safety (Cohorts), School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.
Frank Peter StrietzelDepartment of Oral Medicine, Dental Radiology and Oral Surgery, Charite Centre 3 for Dental, Oral and Maxillary Medicine, Charite - Medical University of Berlin, Berlin, Germany.
Pathawee KhongkhunthianCenter of Excellence for Dental Implantology, Faculty of Dentistry, Chiang Mai University, Chiang Mai, 50200, Thailand. pathaweek@gmail.com.

Funding

Chiang Mai University R000023419
6 · The paper itself

Abstract

objective• To systematically determine the effectiveness of biphasic calcium phosphate (BCP) as bone substitute materials (BSM) compared to other BSMs for new bone formation in dental implant treatment through a network meta-analysis (NMA). MATERIALS AND

method• Following PRISMA-NMA guidelines, randomized controlled trials (RCTs) on lateral sinus augmentation and dental implants comparing BCP with other BSMs for histomorphometric new bone formation were included. Studies were retrieved from MEDLINE, Cochrane, Scopus, and Embase (up to November 2024), with quality assessed via the Cochrane risk of bias 2 (RoB2.0) tool. Analysis included direct and network meta-analyses using a random-effects model, with SUCRA scores determining treatment rankings. The PROSPERO registration number was CRD42024607526.

results• Of 268 studies, 11 met criteria, covering 283 patients and 362 sinus augmentations using autografts (AB), allografts (AL), beta tricalcium phosphate (TCP), BCP, and xenografts (Xeno). NMA showed AB resulted in 12.33% more new bone formation than BCP (95% CI: 10.74, 13.93), with AL showing 5.14% more (95% CI: 3.33, 6.95). Xeno showed 4.14% less bone formation than BCP (95% CI: -6.38, -1.90). AB ranked highest for new bone formation, followed by AL, BCP, TCP, and Xeno. Residual graft material was highest in Xeno (6.21%; 95% CI: 2.81, 9.61).

conclusion• BCP demonstrated sufficient new bone formation, outperforming xenografts in both bone formation and residual graft material. While autografts and allografts exhibited superior bone regeneration, BCP remains an effective option for bone augmentation treatments.

Indexed as

Bone SubstitutesHydroxyapatitesOsteogenesisSinus Floor AugmentationDental ImplantsHumansRandomized Controlled Trials as TopicBone SubstitutesDental Implantshydroxyapatite-beta tricalcium phosphateHydroxyapatitesBCPBiphasic calcium phosphateDental implantsHistomorphometryHydroxyapatite-beta tricalcium phosphateNetwork meta-analysisSinus floor augmentation

Identifiers

PMID40663189
PMCPMC12263524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.